207 related articles for article (PubMed ID: 1003526)
1. Effect of BCG (Tice strain) on primary sensitization to 2,4-dinitrochlorobenzene and on established delayed hypersensitivity in human malignant melanoma.
Mavligit GM; Gutterman JU; Hersh EM
J Natl Cancer Inst; 1976 Oct; 57(4):749-51. PubMed ID: 1003526
[TBL] [Abstract][Full Text] [Related]
2. Intralesional treatment of recurrent metastatic cutaneous malignant melanoma: a randomized prospective study of intralesional Bacillus Calmette-Guerin versus intralesional dinitrochlorobenzene.
Cohen MH; Jessup JM; Felix EL; Weese JL; Herberman RB
Cancer; 1978 Jun; 41(6):2456-63. PubMed ID: 657108
[TBL] [Abstract][Full Text] [Related]
3. [Cross allergies following sensitization with dinitrochlorbenzol (DNCB)].
Djawari D; Körner E; Haneke E
Hautarzt; 1980 Apr; 31(4):198-202. PubMed ID: 7399912
[TBL] [Abstract][Full Text] [Related]
4. A technique for intensifying BCG sensitivity.
Parmett SR; Klein E
J Med; 1975; 6(3-4):213-6. PubMed ID: 1104733
[TBL] [Abstract][Full Text] [Related]
5. Active specific and active non-specific immunotherapy in patients with malignant melanoma.
Kokoschka EM; Cerni C; Micksche M
Oncology; 1977; 34(5):229-33. PubMed ID: 917456
[TBL] [Abstract][Full Text] [Related]
6. [Immunotherapy of malignant melanoma (active specific and non-specific immune stimulation) (author's transl)].
Kokoschka EM; Micksche M
Wien Klin Wochenschr; 1976 Nov; 88(21):690-6. PubMed ID: 1007279
[TBL] [Abstract][Full Text] [Related]
7. Immunological studies in psoriasis. The quantitative evaluation of cell-mediated immunity in patients with psoriasis by experimental sensitization to 2,4-dinitrochlorobenzene.
Obalek S; Haftek M; Sliński W
Dermatologica; 1977; 155(1):13-25. PubMed ID: 303184
[TBL] [Abstract][Full Text] [Related]
8. Skin sensitization to 2, 4 dinitrochlorobenzene (DNCB) in the first months of life.
Cassimos C; Kanakoudi-Tsakalidis F; Spyroglou K; Ladianos M; Tzaphi R
J Clin Lab Immunol; 1980 Mar; 3(2):111-3. PubMed ID: 7205930
[TBL] [Abstract][Full Text] [Related]
9. DNCB reactivity and prognosis in 419 patients with malignant melanoma.
Camacho ES; Pinsky CM; Braun DW; Golbey RB; Fortner JG; Wanebo HJ; Oettgen HF
Cancer; 1981 May; 47(10):2446-50. PubMed ID: 7272900
[TBL] [Abstract][Full Text] [Related]
10. DNCB skin test in cases of malignant melanoma.
Ehring E; Loth H
J Cancer Res Clin Oncol; 1981; 102(2):185-7. PubMed ID: 7338536
[TBL] [Abstract][Full Text] [Related]
11. Effects of murine tumors on delayed hypersensitivity to dinitrochlorobenzene. I. Description of anergy caused by transplanted tumors.
Jessup JM; Cohen MH; Tomaszewski MM; Felix EL
J Natl Cancer Inst; 1976 Nov; 57(5):1077-84. PubMed ID: 1003543
[TBL] [Abstract][Full Text] [Related]
12. [Studies on the immune status of melanoma patients: cell-mediated immune reactions in intracutaneous and epicutaneous tests in the lymphocyte transformation test and the leukocyte-migration inhibition test before and during BCG immunotherapy (author's transl)].
Knopf B; Wätzig V; Knöll B
Arch Geschwulstforsch; 1978; 48(8):722-8. PubMed ID: 753194
[TBL] [Abstract][Full Text] [Related]
13. [Immunological reactions of skin melanoma patients to nonspecific and adaptive immunotherapy].
Trapeznikov NN; Iavorskiĭ VV; Kadagidze ZG; Malaev SG; Kupin VI
Vopr Onkol; 1977; 23(8):27-33. PubMed ID: 906404
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of skin testing with dinitrochlorobenzene in patients with head and neck cancer.
Osoba D; Kersey PA; Clark RM; Rosen IB
Can J Surg; 1980 Jan; 23(1):43-4. PubMed ID: 7363157
[TBL] [Abstract][Full Text] [Related]
15. BCG in cancer therapy: theoretical bases of immunotherapy.
Dodd MJ
Am J Nurs; 1979 Feb; 79(2):310-4. PubMed ID: 311587
[No Abstract] [Full Text] [Related]
16. Adoptive transfer and specific active immunization of patients with malignant melanoma.
Seigler H; Buckley CE; Sheppard LB; Horne BJ; Shingleton WW
Ann N Y Acad Sci; 1976; 277(00):522-32. PubMed ID: 1069561
[No Abstract] [Full Text] [Related]
17. [Experiences with DNCB sensitization in normal human individuals of various age groups (author's transl)].
Bürkle PA; Tönnesmann E; Ahnefeld S; Nobbe F; Federlin K
Z Immunitatsforsch Exp Klin Immunol; 1976 Apr; 151(2):153-65. PubMed ID: 134535
[TBL] [Abstract][Full Text] [Related]
18. [2,4-dinitrochlorobenzene (DNCB) in the study of delayed hypersensitivity in some infectious diseases].
Cirelli A; D'Amato C; Lanzalone CM
Boll Soc Ital Biol Sper; 1974 Aug; 50(15):1157-62. PubMed ID: 4549182
[No Abstract] [Full Text] [Related]
19. [Activity of 2,4 dinitrochlorbenzene skin tests during the course of immunotherapy of malignant melanomas].
Richter J; Duchková H; Kubíková M
Cas Lek Cesk; 1975 Sep; 114(39):1201-3. PubMed ID: 1182748
[No Abstract] [Full Text] [Related]
20. Sequential evaluation of general immune competence in cancer patients: correlation with clinical course.
Eilber FR; Nizze JA; Morton DL
Cancer; 1975 Mar; 35(3):660-5. PubMed ID: 234294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
